AmplifyBio, which plans to move to a 350,000-square-foot facility in New Albany, was named one of the most innovative companies to watch in the region in the 2022 Columbus Inno BizTech Fire Awards that highlight up and coming companies and entrepreneurs. The Columbus Business First annual awards program which recognizes innovation in science and technology named 14 honorees this year. AmplifyBio is an expert contract research organization that creates commercial drug development solutions ranging from CRO needs to cell and gene therapy and advanced therapy testing. Its accredited team designs innovative paths to produce globally recognized studies and more.

AmplifyBio is expanding to meet significant unmet market demand, focusing on the characterization and safety of advanced therapies with services to complement the current safety, efficacy, and toxicology testing services. With this investment, the company will undergo extensive hiring for research and development positions through 2023. Since its launch in 2021, AmplifyBio has grown rapidly by leveraging decades of experience in creating complex systems in support of advanced therapies using a variety of modern clinical and commercial drug development solutions. It operates facilities in West Jefferson and San Francisco.

“We are excited to expand our presence in the greater Columbus area, specifically New Albany,” said J. Kelly Ganjei, AmplifyBio CEO. “We believe the innovation platform we are bringing to the region is synergistic with and reflective of the collaborative environment that I first noticed when I came to Ohio.”